Actualités
September 21, 2020
Download the document
A management of patients suffering from Alzheimer's disease at the heart of the Group's concerns
With an estimated of 100 million new patients diagnosed worldwide by 2050, the importance of treating Alzheimer's disease remains a priority for ORPEA Group.
